Tag: Drugs

Search News
Categories
Archives
2019 ASCO Annual Meeting

4th June 2019

Professor Peter Schmid, Lead of the Centre for Experimental Cancer Medicine at the Barts Cancer Institute, Queen Mary University of London, attended this year’s ASCO Annual Meeting and today presented updated survival data from the IMpassion130 trial.

Read more

AR alterations in prostate cancer

16th May 2019

Recent findings from a study published in JAMA Oncology have identified genetic markers within blood samples which may indicate whether patients with prostate cancer will respond to hormonal therapies. The study may represent an important step forward for the development of more personalised treatments for advanced prostate cancer.

Read more

Therapy for high-grade glioma

2nd April 2019

A phase I clinical trial that set out to assess the safety of a new combination therapy for a type of aggressive brain tumour has found the treatment to be well tolerated in patients. The trial used a treatment combination of ADI-PEG20, pemetrexed and cisplatin, which showed encouraging efficacy in patients with recurrent high-grade gliomas (HGGs), a disease for which little progress has been made over the last few decades.

Read more

Resistance in Ovarian Cancer

13th March 2019

Ovarian Cancer Awareness Month This month is Ovarian Cancer Awareness Month. In the UK each year, around 7,300 women are diagnosed with ovarian cancer, making it the sixth most common cancer type in females. Here at the Barts Cancer Institute, our researchers are working to better understand the biology of ovarian cancer and translate this knowledge into […]

Read more

Treatment for advanced kidney cancer

13th February 2019

A combination therapy has shown powerful anticancer responses in patients with a type of advanced kidney cancer in a new international phase III clinical trial (KEYNOTE-426). Treatment with the combination therapy resulted in significant increases in overall survival when compared with the current standard of care, and the findings will help to provide a vital new treatment option for patients with this disease.

Read more

Tackling tumour scar tissue could be key to treating pancreatic cancer

11th February 2019

The first study in the world to take a detailed look at scar tissue in human pancreatic cancer has revealed a range of different scar tissue types that could help clinicians predict which patients will respond best to particular treatments.

Read more

Search News
Categories
Archives